AQR Capital Management - REPROS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q2 2015$337,000
-52.7%
47,097
-43.2%
0.00%
-50.0%
Q1 2015$713,000
+194.6%
82,900
+242.6%
0.00%
+100.0%
Q4 2014$242,000
+55.1%
24,200
+53.6%
0.00%
Q3 2014$156,000
-57.1%
15,759
-25.2%
0.00%
-100.0%
Q2 2014$364,000
-27.2%
21,059
-25.2%
0.00%
-50.0%
Q1 2014$500,000
-2.9%
28,1590.0%0.00%0.0%
Q4 2013$515,000
-45.7%
28,159
-20.4%
0.00%
-33.3%
Q3 2013$948,000
-84.9%
35,359
-89.6%
0.00%
-86.4%
Q2 2013$6,283,000
+773.9%
340,559
+645.9%
0.02%
+633.3%
Q4 2012$719,00045,6550.00%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,132,367$8,096,0001.86%
DESTRIER CAPITAL MANAGEMENT LLC 329,030$2,353,0000.56%
RTW INVESTMENTS, LP 229,364$1,640,0000.48%
EDMOND DE ROTHSCHILD (SUISSE) S.A. 182,500$1,305,0000.41%
GENERAL AMERICAN INVESTORS CO INC 601,553$4,301,0000.35%
Baker Brothers Advisors 1,955,944$13,985,0000.12%
CQS Cayman LP 240,000$1,716,0000.10%
Gruss Capital Management LP 304,000$2,174,0000.08%
J. Goldman & Co LP 101,881$728,0000.04%
Squarepoint Ops LLC 18,800$134,0000.04%
View complete list of REPROS THERAPEUTICS INC shareholders